[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Androgen Deprivation Therapy (ADT) Market Report 2016

September 2016 | 115 pages | ID: UA819AD351DEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Androgen Deprivation Therapy (ADT)

Revenue, means the sales value of Androgen Deprivation Therapy (ADT)

This report studies sales (consumption) of Androgen Deprivation Therapy (ADT) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Pfizer Inc. (USA)
  • Abbott Laboratories (USA)
  • Genentech Inc. (USA)
  • GlaxoSmithKline Plc (UK)
  • Immunomedics, Inc. (USA)
  • Indevus Pharmaceuticals Inc. (USA)
  • Novartis AG (Switzerland)
  • OSI Pharmaceuticals, Inc. (USA)
  • Paladin Labs Inc. (Canada)
  • ALZA Corporation (USA)
  • Amgen Inc. (USA)
  • AstraZeneca PLC (UK)
  • Medimmune, LLC (USA)
  • Bristol-Myers Squibb Company (USA)
  • Cell Genesys Inc. (USA)
  • Dendreon Corporation (USA)
  • EUSA Pharma, (USA) Inc. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Progenics Pharmaceuticals, Inc. (USA)
  • Sanofi-Aventis SA (France)
  • Spectrum Pharmaceuticals, Inc. (USA)
  • Takeda Pharmaceutical Company Limited (Japan)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Androgen Deprivation Therapy (ADT) in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Androgen Deprivation Therapy (ADT) Market Report 2016

1 ANDROGEN DEPRIVATION THERAPY (ADT) OVERVIEW

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
1.2 Classification of Androgen Deprivation Therapy (ADT)
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Androgen Deprivation Therapy (ADT)
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Androgen Deprivation Therapy (ADT) (2011-2021)
  1.4.1 USA Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2021)
  1.4.2 USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)

2 USA ANDROGEN DEPRIVATION THERAPY (ADT) COMPETITION BY MANUFACTURERS

2.1 USA Androgen Deprivation Therapy (ADT) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Androgen Deprivation Therapy (ADT) Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Androgen Deprivation Therapy (ADT) Average Price by Manufactures (2015 and 2016)
2.4 Androgen Deprivation Therapy (ADT) Market Competitive Situation and Trends
  2.4.1 Androgen Deprivation Therapy (ADT) Market Concentration Rate
  2.4.2 Androgen Deprivation Therapy (ADT) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA ANDROGEN DEPRIVATION THERAPY (ADT) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Androgen Deprivation Therapy (ADT) Sales and Market Share by Type (2011-2016)
3.2 USA Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2011-2016)
3.3 USA Androgen Deprivation Therapy (ADT) Price by Type (2011-2016)
3.4 USA Androgen Deprivation Therapy (ADT) Sales Growth Rate by Type (2011-2016)

4 USA ANDROGEN DEPRIVATION THERAPY (ADT) SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Androgen Deprivation Therapy (ADT) Sales and Market Share by Application (2011-2016)
4.2 USA Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer Inc. (USA)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
  5.2.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
  5.3.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
  5.4.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
  5.5.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
  5.6.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
  5.7.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
  5.8.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
  5.9.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
  5.10.2 Androgen Deprivation Therapy (ADT) Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)

6 ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURING COST ANALYSIS

6.1 Androgen Deprivation Therapy (ADT) Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST (2016-2021)

10.1 USA Androgen Deprivation Therapy (ADT) Sales, Revenue Forecast (2016-2021)
10.2 USA Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2016-2021)
10.3 USA Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2016-2021)
10.4 Androgen Deprivation Therapy (ADT) Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Androgen Deprivation Therapy (ADT)
Table Classification of Androgen Deprivation Therapy (ADT)
Figure USA Sales Market Share of Androgen Deprivation Therapy (ADT) by Type in 2015
Table Application of Androgen Deprivation Therapy (ADT)
Figure USA Sales Market Share of Androgen Deprivation Therapy (ADT) by Application in 2015
Figure USA Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2011-2021)
Figure USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2011-2021)
Table USA Androgen Deprivation Therapy (ADT) Sales of Key Manufacturers (2015 and 2016)
Table USA Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers
Figure 2016 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers
Table USA Androgen Deprivation Therapy (ADT) Revenue by Manufacturers (2015 and 2016)
Table USA Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table 2016 USA Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table USA Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Androgen Deprivation Therapy (ADT) Average Price of Key Manufacturers in 2015
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 3 Manufacturers
Figure Androgen Deprivation Therapy (ADT) Market Share of Top 5 Manufacturers
Table USA Androgen Deprivation Therapy (ADT) Sales by Type (2011-2016)
Table USA Androgen Deprivation Therapy (ADT) Sales Share by Type (2011-2016)
Figure USA Androgen Deprivation Therapy (ADT) Sales Market Share by Type in 2015
Table USA Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2011-2016)
Table USA Androgen Deprivation Therapy (ADT) Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Androgen Deprivation Therapy (ADT) by Type (2011-2016)
Table USA Androgen Deprivation Therapy (ADT) Price by Type (2011-2016)
Figure USA Androgen Deprivation Therapy (ADT) Sales Growth Rate by Type (2011-2016)
Table USA Androgen Deprivation Therapy (ADT) Sales by Application (2011-2016)
Table USA Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2011-2016)
Figure USA Androgen Deprivation Therapy (ADT) Sales Market Share by Application in 2015
Table USA Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2011-2016)
Figure USA Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Androgen Deprivation Therapy (ADT) Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)
Figure Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)
Figure Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
Table Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2015
Table Major Buyers of Androgen Deprivation Therapy (ADT)
Table Distributors/Traders List
Figure USA Androgen Deprivation Therapy (ADT) Production and Growth Rate Forecast (2016-2021)
Figure USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate Forecast (2016-2021)
Table USA Androgen Deprivation Therapy (ADT) Production Forecast by Type (2016-2021)
Table USA Androgen Deprivation Therapy (ADT) Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories